CSAM Health AS has acquired Databyrån AB, makers of ProSang - an advanced Laboratory Information Management System that simplifies the enire managment of blood, from blood donor call-up to transfusion. With this acquisition, CSAM adds an exciting new specialized product area to its leading portfolio of eHealth niche solutions in the Nordics.
More information is available at CSAM's website.
About Priveq Investment
For more than 30 years, Priveq Investment has invested in profitable growth companies. The business concept is to generate value through long-term investments and active ownership in unlisted growth companies. Since 1983, approximately SEK 3,5 billion has been invested and Priveq Investment and its employees have carried out 122 investments and been involved in taking 25 companies to an IPO. The current portfolio consists of 16 companies which has a total revenue of approximately SEK 5.6 billion and 2,300 employees. Some of the current portfolio companies are 21 Grams, Crem International, Ports Group, QleanAir Scandinavia and Visual Art. Behind Priveq Investment is essentially a number of long-term, institutional pension funds in the Nordics and Europe, for example Skandia Liv, Fjärde AP-fonden, Kommunal Landspensjonskasse (KLP) and Europeiska Investeringsfonden (EIF). Priveq Advisory AB acts as investment advisor to the Priveq Funds.
More information is available at www.priveq.se.